Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
The European Journal of Health Economics
Erschienen in: The European Journal of Health Economics 7/2014

01.09.2014 | Editorial

HTA in Central and Eastern European countries; the 2001: A Space Odyssey and efficiency gain

verfasst von: L. Gulácsi, M. Péntek

Erschienen in: The European Journal of Health Economics | Ausgabe 7/2014

Einloggen, um Zugang zu erhalten

Excerpt

Most of the countries in Central and Eastern Europe (CEE) experienced a decrease of their gross domestic product (GDP) due to the financial crisis, followed by a longer than projected stagnation period suffering from the lack of economic growth. While several papers have been published on the impact of the crisis on health care systems in the past years, very few of them were focused on the health status of the population, and almost none of them provided valid data on health loss due to the crises. Numerous papers focused on Greece and on those countries that were affected most by the recession [1, 2]. However, there is limited knowledge on the impact of the economic recession on health and health care in the CEE member states of the European Union (EU). …
Literatur
1.
Kousoulis, A.A., Angelopoulou, K.E., Lionis, C.: Exploring health care reform in a changing Europe: Lessons from Greece. Eur J Gen Pract 19(3), 194–199 (2013)CrossRefPubMed
2.
Vandoros, S., Hessel, P., Leone, T., Avendano, M.: Have health trends worsened in Greece as a result of the financial crisis? A quasi-experimental approach. Eur J Public Health 23(5), 727–731 (2013)CrossRefPubMed
3.
Eris M. (2012): Improving Health Outcomes and System in Hungary. OECD Economics Department Working Papers, No. 961. OECD
4.
Gaál, P., Sz, Szigeti, Panteli, D., Gaskins, M., van Ginneken, E.: Major challenges ahead for Hungarian health care; The health sector in Hungary is facing its most serious crisis since the fall of the communist regime. BMJ 343, d7657 (2011). doi:10.​1136/​bmj.​d7657 CrossRefPubMed
5.
OECD 2010, “Health care systems: Getting more value for money”, OECD Economics Department Policy Notes, No. 2
6.
Baji, P., Boncz, I., Jenei, G., Gulácsi, L.: Comparing cost-sharing practices for pharmaceuticals and health care services among four Central European countries. Society and Economy 34(2), 221–240 (2012)CrossRef
7.
Pavlova, P., Arsenijevic, J., Goot, W., van Merode, G.G.: Projection of health service consumption and patient payment revenues in CEE countries using system dynamics modeling. Society and Economy 34(2), 359–378 (2012)CrossRef
8.
Baji, P., Pavlova, M., Gulácsi, L., Groot, W.: User fees for public health care services in Hungary: Expectations, experience, and acceptability from the perspectives of different stakeholders. Health Policy 102(2–3), 255–262 (2011)CrossRefPubMed
9.
Karanikolos, M.M.P., Cylus, J., Thomson, S., Basu, S., Stuckler, D., Mackenbach, J.P., McKee, M.: Financial crisis, austerity, and health in Europe. Lancet 381, 1323–1331 (2013)CrossRefPubMed
10.
McCormick, J., Mehta, G., Olesen, H.V., Viviani, L., Macek Jr, M., Mehta, A.: European Registry Working Group Comparative demographics of the European cystic fibrosis population: a cross-sectional database analysis. Lancet 375(9719), 1007–1013 (2010)CrossRefPubMed
11.
12.
Érsek, K., Kovács, T., Wimo, A., Kárpáti, K., Brodszky, V., Péntek, M., Jönsson, L., Gustavsson, A., McDaid, D., Kenigsberg, P.A., Valtonen, H., Gulácsi, L.: Costs of dementia in Hungary. J. Nutrition Health Aging 14(8), 633–639 (2010)CrossRef
13.
Péntek, M., Horváth, C., Boncz, I., Falusi, Z., Tóth, E., Sebestyén, A., Májer, I., Brodszky, V., Gulácsi, L.: Epidemiology of osteoporosis related fractures in Hungary from the nationwide health insurance database, 1999-2003. Osteoporos. Int. 19(2), 243–249 (2008)CrossRefPubMed
14.
Sebestyén, A., Boncz, I., Sándor, J., Nyárády, J.: Effect of surgical delay on early mortality in patients with femoral neck fracture. Int. Orthop. 32(3), 375–379 (2008)PubMedCentralCrossRefPubMed
15.
Boncz, I., Sebestyén, A., Pintér, I., Betlehem, J., Kriszbacher, I., Csere, T., Mangel, L., Bódis, J.: Age group specific gap between treatment cost of and mortality due to breast and colorectal cancer. J. Clin. Oncol. 25(28), 4501–4502 (2007)CrossRefPubMed
16.
Boncz, I., Sebestyén, A., Pintér, I., Battyány, I., Ember, I.: The effect of an organized, nationwide breast cancer screening programme on non-organized mammography activities. J. Med. Screen. 15(1), 14–17 (2008)CrossRefPubMed
17.
Laki, J., Mónok, G., Pálosi, M., Gajdácsi, J.Z.: Economical aspect of biological therapy in inflammatory conditions in Hungary. Expert Opin Biol Ther. 13(3), 327–337 (2013)CrossRefPubMed
18.
Minier, T., Péntek, M., Brodszky, V., Ecseki, A., Kárpáti, K., Polgár, A., Czirják, L., Gulácsi, L.: Cost-of-illness of patients with systemic sclerosis in a tertiary care centre. Rheumatology (Oxford) 49(10), 1920–1928 (2010)CrossRef
19.
Inotai, A., Rojkovich, B., Fülöp, A., Jászay, E., Agh, T., Mészáros, A.: Health-related quality of life and utility in patients receiving biological and non-biological treatments in rheumatoid arthritis. Rheumatol. Int. 32(4), 963–969 (2012)CrossRefPubMed
20.
Putrik, P., Ramiro, S., Kvien, T.K., Sokka, T., Uhlig, T., Boonen, A.: on behalf of Equity in Clinical Eligibility Criteria for RA treatment Working Group. Variations in criteria regulating treatment with reimbursed biologic DMARDs across European countries. Are differences related to country’s wealth? Ann. Rheum. Dis. (2013). doi:10.​1136/​annrheumdis-2013-203819
21.
Antonanzas, F., Rodriguez-Ibeas, R.: Channeling health economics research initiatives to improve decision-making process in EU. Eur. J Health Econ 14, 847–852 (2013)CrossRefPubMed
22.
Kaló, Z., Landa, K., Dolezal, T., Vokó, Z.: Transferability of National Institute for Health and Clinical Excellence recommendations for pharmaceutical therapies in oncology to Central-Eastern European countries. Eur. J. Cancer Care (2012). doi:10.​1111/​j.​1365-2354.​2012.​01351.​x
23.
Gulácsi, L., Orlewska, E., Péntek, M.: Health economics and health technology assessment in Central and Eastern Europe: a dose of reality. Eur J Health Econ 13(5), 525–531 (2012)CrossRefPubMed
24.
Ozieranski, P., McKee, M., King, L.: The politics of health technology assessment in Poland. Health Policy 108(2–3), 178–193 (2012)CrossRefPubMed
25.
Jóna G., A GYEMSZI Technológia-értékelő Főosztály tapasztalataiból. Corvinus Health Policy Series Conference 2011.10.03. Budapest
26.
Cleemput, I., Neyt, M., Thiry, N., de Laet, C., Leys, M.: Using threshold values for cost per quality-adjusted life year gained in health care decisions. Int. J. Technol. Assess. Health Care 27, 71–76 (2011)CrossRefPubMed
27.
McCabe, C., Claxton, K., Culyer, A.J.: The NICE Cost-Effectiveness threshold. What it is and What that Means, Pharmacoeconomics 26(9), 733–744 (2008)
Metadaten
Titel
HTA in Central and Eastern European countries; the 2001: A Space Odyssey and efficiency gain
verfasst von
L. Gulácsi
M. Péntek
Publikationsdatum
01.09.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
The European Journal of Health Economics / Ausgabe 7/2014
Print ISSN: 1618-7598
Elektronische ISSN: 1618-7601
DOI
https://doi.org/10.1007/s10198-014-0608-2

Weitere Artikel der Ausgabe 7/2014

The European Journal of Health Economics 7/2014 Zur Ausgabe

Original Paper

Choice of insurer for basic health insurance restricted by supplementary insurance

Original Paper

A multi-criteria decision analysis perspective on the health economic evaluation of medical interventions

Original Paper

Health tourism on the rise? Evidence from the Balance of Payments Statistics

Original Paper

Cost-effectiveness of lung transplantation and its evolution: the Portuguese case

Original Paper

Public funding of pharmaceuticals in the Netherlands: investigating the effect of evidence, process and context on CVZ decision-making

Original Paper

Employment effects of hospital privatization in Germany